Dealing With Vaccine Allergies

NIROSHA REDDY | July 4, 2017

article image
However, the redeeming quality of a vaccine-triggered allergy is that it is temporary, which means most patients outgrow it within a matter of two to five. But these allergies and the myths surrounding them are often used to avoiding immunization altogether, which can have severe consequences for the patient and their progeny. As per experts in the field, the most common symptom of an allergic reaction to vaccines is fever, which shouldn’t contraindicate future doses.

Spotlight

Pharma Marketing Group

Pharma Marketing Group`s main focus on patient acquisition. Generating leads for Diabetic Supplies, Back & Knee Braces, Compounding Medication such as Pain Patches, Scar, Wound , Pain, and Metabolic Supplements, We focus on internet lead generation combined with call center verification of prospective leads. Anyone wishing to contact us please.We just actively looking for Sales Reps to Join our new Telemedicine DME program for Back Braces and Tens Units.

OTHER ARTICLES

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 6, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

Coronavirus Pandemic Brings Hundreds Of U.S. Clinical Trials To A Halt

Article | April 11, 2020

Rene Roach fired off a quick email in late March for an update on a colorectal cancer clinical trial for which she hoped to qualify. Worried about the coronavirus, she asked, almost as an afterthought, whether the study had been put on hold because of the pandemic.The answer crushed her: It had been. "That's when COVID-19 shut down everything," says Roach, 50, of Germantown, Md. Roach assumed that there would be workarounds for patients like her, who have stage IV cancer. These patients often depend on clinical trials as their best chance to knock cancer out when other therapies have failed. For now, she's being treated with traditional chemotherapy, but she was counting on the drug cocktail from the clinical trial. She figures if chemo was going to rid her body of cancer for good, it would have done so already.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | March 4, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

Spotlight

Pharma Marketing Group

Pharma Marketing Group`s main focus on patient acquisition. Generating leads for Diabetic Supplies, Back & Knee Braces, Compounding Medication such as Pain Patches, Scar, Wound , Pain, and Metabolic Supplements, We focus on internet lead generation combined with call center verification of prospective leads. Anyone wishing to contact us please.We just actively looking for Sales Reps to Join our new Telemedicine DME program for Back Braces and Tens Units.

Events